NCT01460615

Cortisone Treatment for the Prevention of Postoperative Pancreatitis and Pancreatitis-induced Complications After Pancreaticoduodenectomy and Distal Pancreatic Resection

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: —
• Sponsor: Tampere University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

The purpose of this randomized, placebo-controlled trial is to investigate whether postoperative pancreatitis and other immediate complications after pancreaticoduodenectomy or distal pancreatic resection may be reduced with cortisone treatment. Treatment is administered to high risk patients (defined by high amount of acinar cells in the cut edge of pancreas).

Conditions

• Postoperative Complications
• Postoperative Pancreatitis

Interventions

Type	Name	Description
DRUG	Hydrocortisone

Timeline

• Start date: 2011-02-01
• Primary completion: 2017-01-01
• Completion: 2017-01-01
• First posted: 2011-10-27
• Last updated: 2018-11-29

Locations

1 site across 1 country: Finland